Our findings agreed with those obtained by the Wang team [74], who reported that managing microbe-induced immune suppressive factors, such as IL-10 and PD-L1, may have profound clinical value, especially during immunizations, although the improvement in inflammatory responses might raise questions about the therapeutic value during infection. This evidence concerns the gene IL10 and infection.